disposition - Globe Thesis

Keyword [disposition] Result: 101 - 120 \| Page: 6 of 8
101.	Application of pharmacokinetic theory to examine roles of transporters and enzymes in intestinal and hepatic drug disposition
102.	The effects of hyperlipidemia on the disposition and metabolism of amiodarone in rats
103.	Hemozoin formation, disposition and detection in Plasmodium species
104.	Drug metabolizing enzyme, drug transporter expression and drug disposition are altered in models of inflammatory liver disease
105.	Altered drug disposition in vivo as a consequence of murine organic anion transporter 3 (Oat3/Slc22a8) deletion
106.	Mechanistic study on the intestinal absorption, metabolism, and disposition of baicalein
107.	Impact of the CYP3A5 polymorphism on the metabolic disposition of calcineurin inhibitors
108.	Examining the regulation of hepatic drug disposition and metabolism by organic anion transporting polypeptide, P-glycoprotein and multidrug resistance-associated protein 2
109.	Impact of nutrient intake (enteral or oral diet) on nutrition status in stroke patients admitted to the Neuroscience Intensive Care Unit (NSICU) and disposition at discharge
110.	Tobramycin disposition in the lung following airway administration
111.	Predicting Drug Disposition by Integrating In Vitro and In Silico Methodology
112.	The effect of body weight on the disposition of flunixin meglumine and gentamicin in miniature horses and quarter horses
113.	The role and relevance of proton-coupled oligopeptide transporters in multiple organ systems: Implications for the regional and systemic disposition of peptides/mimetics
114.	Stroke care in academic health centers: Does third party payer type affect equity of physical therapy services and discharge disposition
115.	Organic Cation Transporters in Drug Disposition and Response
116.	An evaluation of pharmacokinetic study design for describing drug disposition in renal failure
117.	NASH alters drug metabolizing enzyme and transporter expression resulting in significant consequences for pharmaceutical disposition and toxicity
118.	A novel encapsulation favorably modifies the skin disposition of topically-applied N,N-diethyl-3-methylbenzamide (DEET)
119.	Characterizing the transport and disposition of resveratrol and its metabolites in the presence of MRP2, BCRP and enterohepatic circulation inhibitors
120.	Evaluation of the Yucatan micropig for assessing the disposition and oral bioavailability of selected compounds
<<First <Prev Next> Last>> Jump to